analytics_image

Vantage Market Research

Blogs-Allergic Rhinitis Drugs Market is Growing at a Phenomenal Pace to Reach USD 1.7 Billion in 2020 in 2020, Globally, By 2028 At 5.3% CAGR

Vantage Market Research | 08 Nov 2022

Healthcare

Allergic Rhinitis Drugs Market is Growing at a Phenomenal Pace to Reach USD 1.7 Billion in 2020 in 2020, Globally, By 2028 At 5.3% CAGR

image

According to analysts at Vantage Market Research, the Global Allergic Rhinitis Drugs Market was valued at USD 1.7 Billion in 2020 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.3% between 2021 to 2028.

Allergic rhinitis is an allergic response that is generated to specific allergens that are present in the environment of the patient such as pollen grains, dust, grass, cat saliva, mold and animal dander and is commonly known as hay 10;The drugs used to treat such allergies come under the class of allergic rhinitis drugs. The market is anticipated to grow owing to the rising awareness among people worldwide regarding the allergic reactions. Moreover, the increasing availability of quality drugs and manufacturing of nasal sprays by manufacturers for efficient treatment of allergic rhinitis is driving the growth of the market.

Over the years with governmental implementation and providing education programs about allergic rhinitis is creating an opportunity for the market. Whereas, having side effects that are rare but can be dangerous and may even be deadly is potentially hampering the growth of market and might restrain the Allergic Rhinitis Drugs Market.

Moreover, the COVID-19 pandemic has adversely impacted the healthcare sector. Due to the mandatory lockdowns imposed by government the market has seen a downfall as companies have found it difficult to find sources for production of these drugs. As a result of which a hike in prices has prominently been forced on the consumers.

Globally, North America is expected to dominate the global allergic rhinitis drugs market with having around more than 50% of revenue share across the globe owing to the presence of majority of pharmaceutical vendors in the region.

Subsequently, Asia-Pacific is expected to be second-highest growing region and is anticipated to have highest CAGR over the next 5 years. The growth in this region is mainly attributable to the rising awareness and availability of efficient treatment options.

Key market players in the global allergic rhinitis drugs market includes Centurion Safety, Pyramex Safety, MSA, and Delta Plus.

Healthcare

Allergic Rhinitis Drugs Market is Growing at a Phenomenal Pace to Reach USD 1.7 Billion in 2020 in 2020, Globally, By 2028 At 5.3% CAGR

08 Nov 2022

Min Read

Historical Data | Base Year 

Add banner

star icon

Access Full Report

Cosmetic Ingredients Market - Global Industry Assessment (2022 - 2028)

This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

Request Sample

Related Reports

Healthcare

Veterinary Care Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Healthcare

Surgical Imaging Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Healthcare

Surgical Imaging Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Latest Blogs

13 Nov 2023

Veterinary Care Market Size, Share & Trends Analysis Report.

Healthcare

13 Nov 2023

Surgical Imaging Market Size, Share & Trends Analysis Report.

Healthcare

13 Nov 2023

Surgical Imaging Market Size, Share & Trends Analysis Report.

Healthcare

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Allergic Rhinitis Drugs Market is Growing at a Phenomenal Pace to Reach USD 1.7 Billion in 2020 in 2020, Globally, By 2028 At 5.3% CAGR